Exogenous Drug Disposition as a Diagnostic Biomarker Strategy for Non-Alcoholic Steatohepatitis
2021 ◽
pp. DMD-MR-2021-000413
Solène MARIE
◽
David K.K. TRIPP
◽
Nathan J. CHERRINGTON
2008 ◽
Vol 48
◽
pp. S14-S15
Z.M. Younossi
◽
M. Jarrar
◽
C. Nugent
◽
M. Randhawa
◽
M. Afendy
◽
...
A Kahraman
◽
S Menziletoglu Yildiz
◽
M Schlattjan
◽
A Kilicarslan
◽
CD Fingas
◽
...
T Csak
◽
A Dolganiuc
◽
B Nath
◽
J Patrasek
◽
K Kodys
◽
...
M Saugspier
◽
C Dorn
◽
C Hellerbrand
A Chatzigeorgiou
◽
R Garcia-Martin
◽
KJ Chung
◽
I Alexaki
◽
A Klotzsche-von Ameln
◽
...
HK Drescher
◽
C Berger
◽
P Fischer
◽
ML Berres
◽
DC Kroy
◽
...
2017 ◽
Vol 55
(05)
◽
pp. e28-e56
R Stauber
◽
W Spindelböck
◽
F Rainer
◽
P Douschan
◽
C Lackner
2018 ◽
Vol 56
(01)
◽
pp. E2-E89
H Witzel
◽
L Pawella
◽
V Rausch
◽
S Mueller
◽
J Schattenberg
◽
...
Kyung‐Hun Lee
◽
Kyoung Jin Lee
◽
Tae‐Yong Kim
◽
Febby Hutomo
◽
Hyun Jin Sun
◽
...